Close this search box.

Securing Lyell Immunopharma’s Cloud Operations: Fidelis Halo

Addressing Security Challenges: Protecting Proprietary Data in the Cloud

San Francisco-based, publicly traded cell therapy company (LYEL), Lyell Immunopharma, is a cloud-first company for which operations rely on cloud services, where they generate and store proprietary data.  

After a thorough requirements definition and series of vendor evaluations, Lyell determined that only Fidelis CloudPassage Halo® provided the means to programmatically define configuration via APIs, allowing it to be seamlessly integrated into Lyell’s automated CICD and Software Development Life Cycle (SDLC) processes. 

“Policy assignments work surprisingly well. I can just set policies for our assets and servers, and those policies apply to any new instances that we spin up.”- Eric Hoffmann, Staff Software Engineer, DevSecOps 

Read the case study to know the results of Fidelis Halo in Lyell Immunopharma’s cyber environment. 

Share this post

Get Started

See Fidelis Security platforms in action. Learn how our fast scalable platforms provide full visibility, deep insights, and rapid response to help security teams worldwide protect, detect, respond, and neutralize against advanced cyber adversaries.